Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 24, 2026
TickeronGET DAILY SIGNALS
SCHD vs SCHV: Weighing Dividend Quality Against Broad Value Exposure

SCHD vs SCHV: Weighing Dividend Quality Against Broad Value Exposure

Key Takeaways

  • Different mandates: SCHD targets high-quality, dividend-paying U.S. equities, while SCHV provides broad exposure to the large-cap value segment of the U.S. market.
  • Holdings breadth: SCHD holds roughly 100–102 names versus approximately 560–570 for SCHV, giving SCHV materially greater diversification.
  • Cost structure: Both are low-cost, passively managed funds, with SCHV charging 0.04% and SCHD charging 0.06% in annual expenses.
  • Sector profile: SCHD leans toward consumer staples, healthcare, and energy, while SCHV skews toward financials, technology, and industrials.
  • Income orientation: SCHD is built around dividend durability and yield, whereas SCHV prioritizes valuation characteristics across the large-cap value universe.
  • Risk and positioning: SCHD is more concentrated and income-driven; SCHV is broader and more diversified, with different sensitivity to sector rotation and interest-rate expectations.

Why These Two Schwab ETFs Often Come Up Together

Investors looking for value and income exposure often find themselves comparing SCHD and SCHV, two low-cost ETFs from the same provider that share a defensive, value-oriented tilt yet approach it differently. They are not direct substitutes: SCHD follows a dividend-quality strategy, while SCHV offers broad large-cap value coverage. In my view, understanding their structural differences matters now because sector rotation, interest-rate expectations, and the back-and-forth between growth and value have made relative positioning important. This comparison looks at index construction, sector exposure, cost, and risk to help clarify which fund may better align with different objectives.

SCHD: A Dividend-Quality Approach

SCHD tracks the Dow Jones U.S. Dividend 100 Index, a market-capitalization-weighted benchmark that selects roughly 100 U.S. companies with strong dividend records, sustainable payout fundamentals, and quality traits such as cash flow and profitability. The fund is passively managed and rebalances periodically. It typically holds around 100–102 stocks, with larger positions including Texas Instruments (TXN), Qualcomm (QCOM), Procter & Gamble (PG), Chevron (CVX), Coca-Cola (KO), Merck (MRK), UnitedHealth Group (UNH), and ConocoPhillips (COP). Sector allocation concentrates in consumer staples, healthcare, technology, and energy. The expense ratio sits at 0.06%. Its core feature is a deliberate focus on durable dividend payers rather than broad value exposure. From what I see, this makes SCHD particularly relevant when income stability is a priority.

SCHV: Broad Large-Cap Value Coverage

SCHV tracks the Dow Jones U.S. Large-Cap Value Total Stock Market Index, a float-adjusted, market-cap-weighted index covering the large-cap value portion of the U.S. equity market. The fund is passively managed and holds approximately 560–570 stocks, providing broad diversification with limited single-stock concentration. Top holdings include Berkshire Hathaway (BRK-B), JPMorgan Chase (JPM), ExxonMobil (XOM), Johnson & Johnson (JNJ), Intel (INTC), Walmart (WMT), AbbVie (ABBV), and Cisco Systems (CSCO). Sector exposure leads with financials, followed by technology, healthcare, industrials, and consumer staples. Its expense ratio of 0.04% ranks among the lowest in the category. Because it captures the full value segment, SCHV delivers wider factor exposure but a lower, less yield-focused dividend profile than SCHD.

Market Backdrop Shaping Both Funds

Both funds sit within the value and income segment of the U.S. equity market, an area influenced in recent cycles by Federal Reserve policy, inflation trends, and the ongoing rotation between growth and value styles. Higher-for-longer interest rates have supported financial-sector earnings while pressuring rate-sensitive defensive stocks. Energy and healthcare, key pillars for SCHD, continue to respond to commodity prices, regulatory shifts, and demographic demand. SCHV’s heavier weighting in financials and semiconductors ties its results more closely to credit conditions, capital-markets activity, and cyclical technology hardware recovery. Sustained interest in low-cost passive vehicles has supported inflows into both, even as sector leadership rotates.

Performance and Positioning: What Stands Out

In recent periods, relative performance has largely followed sector leadership. SCHD’s concentration in consumer staples, healthcare, and energy has delivered more defensive characteristics, while its technology allocation has allowed some participation in broader rallies. SCHV’s wider footprint, anchored by financials, industrials, and technology, has created greater sensitivity to cyclical reflation and earnings cycles at large banks and semiconductor companies. As a result, SCHV has tended to carry a slightly higher beta to the overall market than SCHD, while SCHD’s emphasis on cash-flow-rich dividend payers has historically produced lower structural volatility and a higher distribution yield. Investors choosing between the two are essentially selecting between targeted income quality and broad value diversification. I also checked this using Tickeron’s AI Screener to see how the funds compare to others in the category.

Tickeron AI Assessment

Based on observable structural factors, Tickeron’s AI would likely favor SCHD in environments that reward defensiveness, income durability, and lower volatility, given its disciplined quality screen and concentrated exposure to cash-generative sectors. Conversely, the model would likely lean toward SCHV when broad value, diversification, and cyclical momentum are more rewarded, reflecting its wider holdings base and lower cost. On balance, the assessment would hinge on prevailing trend consistency and sector momentum: if defensive and income-oriented leadership persists, SCHD may hold the edge; if a broad-based value and cyclical rotation dominates, SCHV’s diversification and 0.04% cost advantage could make it the more favorable candidate. Neither outcome constitutes a recommendation, and positioning should be evaluated against each investor’s goals and risk tolerance.

Using Tickeron’s AI Screener for ETF Comparisons

In my own research process I turn to Tickeron’s AI Screener when I want to filter ETFs and stocks by technical patterns, fundamentals, and AI-driven signals. It lets me scan thousands of names with customizable criteria and quickly surface ideas that align with a particular thesis, which proved helpful when weighing SCHD against SCHV.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD, SCHV

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


SCHD sees MACD Histogram crosses below signal line

SCHD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 29 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 50 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

SCHD moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.

Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 285 of 363 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), PepsiCo (NASDAQ:PEP), Abbott Laboratories (NYSE:ABT).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 57.94B. The market cap for tickers in the group ranges from 363.12M to 417.06B. CVX holds the highest valuation in this group at 417.06B. The lowest valued company is AMSF at 363.12M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -6%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 5%. GIS experienced the highest price growth at 4%, while VRTS experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 58%. For the same stocks of the ETF, the average monthly volume growth was 35% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 42
Price Growth Rating: 48
SMR Rating: 42
Profit Risk Rating: 60
Seasonality Score: 9 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.